Efficacy and safety of anaplastic lymphoma kinase inhibitors for non–small cell lung cancer: A systematic review and network meta‐analysis
Abstract Background To assess the efficacy and safety of anaplastic lymphoma kinase inhibitors (ALKIs) for the treatment of advanced‐stage ALK rearrangement‐positive non–small cell lung cancer (NSCLC). Methods We searched PubMed, EMBASE, and the Cochrane Library for randomized controlled trials (RCT...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wiley
2023-04-01
|
| Серии: | Thoracic Cancer |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1111/1759-7714.14824 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|